We’re excited to announce that the 3rd EuroQol Asia Regional Meeting 2026 will take place on: 📅 9–10 June 2026 📍 Village Hotel Changi, Singapore 🌐 Hybrid Format (In-Person & Virtual) Join early-career and senior researchers, HTA practitioners, policymakers, and EQ-5D users from across the Asia-Pacific region for two days of shared learning, collaboration, and…

We are excited to report that NICE – National Institute for Health and Care Excellence recently posted news containing information on the adoption of the new UK EQ-5D-5L value set. NICE stated that it “will introduce the new value set for use alongside EQ-5D-5L following peer review and publication.” A webinar is available with more…

We are pleased to announce that the EuroQol Research Foundation’s Annual Report for the financial year 2024/25 is now available. Please visit the EuroQol website to access the full report This report highlights the Foundation’s activities and achievements over the past year, a period marked by key advances in implementing the Strategic Plan 2024–2028.  Major…

Join us for the 3rd EuroQol UK & Ireland Regional Meeting 2026 on 25 March 2026 in Sheffield, UK—a unique opportunity to connect, share insights, and explore the latest developments in EQ-5D research. We invite you to submit an abstract through the EuroQol Abstracts Submission Portal at the latest by 7 January 2026, 23.59 CET. For further information, please…

As the Science Team continues to grow, we are excited to announce a new departmental structure designed to better support the expanding scope and complexity of our work. Going forward, the Science Department will be organized into two dedicated sub-teams: The Scientific Team, focused on advancing high-quality research and driving scientific innovation The Community Support…

Please be informed that, effective 1 August 2025, the EuroQol Office will discontinue offering the Proxy2 as a separate mode of administration (MOA). The Proxy2 is designed for use by a caregiver (the proxy) who knows the respondent well and who rates how they believe the respondent would rate their own health, if the respondent…

We’re excited to share a record number of research submissions this year: 📝 104 proposals received for the 19th RFP (up 55% from last year) 📚 134 abstracts submitted for the 42nd Plenary (up 23% from last year) Thank you to all who submitted their work!

Over the duration of the COVID-19 pandemic emergency, the EuroQol Research Foundation offered study-specific licenses free of charge to commercial users wishing to use EQ-5D instruments in studies aimed at testing COVID-19 treatments or diagnostic tools. During this period, numerous commercial organisations undertook COVID-19 related research around the world using EQ-5D instruments – with EuroQol…

Launched as an approved EuroQol Group instrument today, the EQ-5D-Y-5L is a new generic measure of health-related quality of life (HRQoL) for use with children and adolescents. The EQ-5D-Y-5L covers the same five dimensions of health in its descriptive system questionnaire as the EQ-5D-Y-3L (formerly EQ-5D-Y), but has five levels of response in each dimension…

An updated EQ-5D-Y-3L User Guide is now available on the EuroQol website.  Changes include: renaming the EQ-5D-Y to the EQ-5D-Y-3L ahead of the launch of a new version of a new EQ-5D youth instrument during 2024 (EQ-5D-Y-5L, which provides five response levels of severity to questions in the descriptive system); revisions to clarify recommended age…